Company Profiles

driven by the PitchBook Platform

Xention

Description

Developer of ion channel-modulating drugs for therapeutic intervention. The company offers drugs for the treatment of atrial fibrillation, overactive bladder, pain and autoimmune diseases.

2002

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$3.14M

Latest Deal Amount

$48.2M

Total Amount Raised

Description

Developer of ion channel-modulating drugs for therapeutic intervention. The company offers drugs for the treatment of atrial fibrillation, overactive bladder, pain and autoimmune diseases.

Website:

www.xention.com

Formerly Known As

Xention Discovery

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery

Primary Office

Unit 5, Quern House Mill Court, Hinton Way, Great Shelford Cambridge CB22 5LDEngland +44 (0)12 2349 3900
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Xention's full profile, request a free trial.

Xention Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Xention Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ABN AMRO BankInvestment BankMinority000 0000000 0000
Albany Venture ManagersVenture CapitalMinority000 0000000 0000
Albion VenturesVenture CapitalMinority000 0000000 0000
BTGCorporationMinority000 0000000 0000
Enterprise VenturesVenture CapitalMinority000 0000000 0000
ABN AMRO Bank Investment Bank
Albany Venture Managers Venture Capital
Albion Ventures Venture Capital
BTG Corporation
Enterprise Ventures Venture Capital

Xention Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Patrick RoundChief Medical Officer, Chief Executive Officer & Head, Development
Rebecca HemsleyDirector, Finance & Chief Financial Officer
James Milnes Ph.DVP, Preclinical Development
John Ford Ph.DCo-Founder & Chief Scientific Officer
Patrick Round Chief Medical Officer, Chief Executive Officer & Head, Development
Rebecca Hemsley Director, Finance & Chief Financial Officer
James Milnes Ph.D VP, Preclinical Development
John Ford Ph.D Co-Founder & Chief Scientific Officer

Xention Board Members (11)

NameRepresentingRoleSinceContact
Info
Alan O'Connell Ph.DSeroba Life SciencesBoard Member000 0000
Andrew ElderAlbion VenturesBoard Member000 0000
Angel MitevSelfBoard Member000 0000
Bruno MontanariOmnes CapitalBoard Member000 0000
Graham Fagg Ph.DSelfBoard Member000 0000
Alan O'Connell Ph.D Board Member Seroba Life Sciences
Andrew Elder Board Member Albion Ventures
Angel Mitev Board Member Self
Bruno Montanari Board Member Omnes Capital
Graham Fagg Ph.D Board Member Self
Request full access to PitchBook